Cover Image

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Patrick Lemoine1, Doron Garfinkel2, Moshe Laudon3, Tali Nir3, Nava Zisapel3,41The Clinique Lyon-Lumière, Meyzieu, France; 2Geriatric-Palliative Department, Shoham Geriatric Medical Center, Pardes Hanna, Israel; 3Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel; 4Department of Neurobiology Fac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lemoine P (Author), Garfinkel D (Author), Laudon M (Author), Nir T (Author), Zisapel N (Author)
Format:	Book
Published:	Dove Medical Press, 2011-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
by: Lemoine P, et al.
Published: (2012)

Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
by: Guerriero F, et al.
Published: (2016)

Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies
by: Goodman DW
Published: (2013)

Comparative Pharmacokinetics of Sustained-Release versus Immediate-Release Melatonin Capsules in Fasting Healthy Adults: A Randomized, Open-Label, Cross-Over Study
by: Shefali Thanawala, et al.
Published: (2024)

Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin
by: Hui Ming Chua, et al.
Published: (2016)

Safety of long-term use of linezolid: results of an open-label study
by: Vazquez JA, et al.
Published: (2016)

Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
by: Samira Ait Abdellah, et al.
Published: (2023)

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
by: Ana Checa-Ros, et al.
Published: (2023)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
by: Taro Kishi, et al.
Published: (2019)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012)

Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
by: Gary B. Kaplan, et al.
Published: (2023)

Hyperconnectivity of the lateral amygdala in long-term methamphetamine abstainers negatively correlated with withdrawal duration
by: Yifan Li, et al.
Published: (2023)

Combining approach bias modification with working memory training during inpatient alcohol withdrawal: an open-label pilot trial of feasibility and acceptability
by: Victoria Manning, et al.
Published: (2019)

Effect of melatonin on insomnia and daytime sleepiness, in patients with obstructive sleep apnea and insomnia (COMISA): A randomized double-blinded placebo-controlled trial
by: Tahereh Madani Motlaq, et al.
Published: (2024)

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion
by: Fawaz S, et al.
Published: (2020)

Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home
by: Hervé Javelot, et al.
Published: (2018)

Neonatal hypertension – a long-term pilot follow-up study
by: Chaudhari T, et al.
Published: (2013)

ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol
by: M. M. Barbieri, et al.
Published: (2020)

Reducing withdrawal and failure rates in introductory programming with subgoal labeled worked examples
by: Lauren E. Margulieux, et al.
Published: (2020)

Heavy Alcohol Consumption Effects on Blood Pressure and on Kidney Structure Persist After Long-Term Withdrawal
by: Sandra Leal, et al.
Published: (2017)

Ziwuliuzhu Acupuncture Modulates Clock mRNA, Bmal1 mRNA and Melatonin in Insomnia Rats
by: Ao Huang, et al.
Published: (2023)

The state of reproductive organs of young and aged male rats with the prolonged administration of letrozole and after its withdrawal
by: О. H. Reznikov, et al.
Published: (2019)

Pharmacokinetic study of prolonged release capsules of mebeverine
by: A. L. Khokhlov, et al.
Published: (2017)

Biocomposite for Prolonged Release of Water-Soluble Drugs
by: Lyghia M. A. Meirelles, et al.
Published: (2023)

Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial
by: Mari Wataya-Kaneda, et al.
Published: (2020)

An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
by: Hidehisa Saeki, et al.
Published: (2024)

Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context
by: Schinco P, et al.
Published: (2014)

Applied technologies to prolong drug release: an integrative review
by: Ana Vithória da Silva Melo, et al.
Published: (2023)

Salivary stimulation by prolonged release of pilocarpine in Sjögren's syndrome.
by: Jesús Rodríguez-Pulido, et al.
Published: (2017)

How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding
by: Michael P. Hengartner
Published: (2020)

Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
by: Yoshikazu Takaesu, et al.
Published: (2023)

Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study
by: Hye Sung Han, et al.
Published: (2024)

Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial
by: Jin Jin, et al.
Published: (2021)

Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term, open-label study
by: Gilbert L'Italien, et al.
Published: (2022)

Therapeutic Inhalation of Hydrogen Gas for Alzheimer's Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study
by: Hirohisa Ono, et al.
Published: (2023)

Melatonin as an effective pharmacocorrector of alimentary obesity resulting from a long-term excessive intake of palm oil
by: Elena Y. Bibik, et al.
Published: (2018)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
by: Paul Glue, et al.
Published: (2020)

Exposure–response model for sibutramine and placebo: suggestion for application to long-term weight-control drug development
by: Han S, et al.
Published: (2015)

Formulation of Melatonin as a Cream and Studying the Release, Diffusion, and Stability of the Cream
by: Mohammed Mahmood Mohammed, et al.
Published: (2009)

Identification of the risk factors for insomnia in nurses with long COVID-19
by: Lingxiao Ye, et al.
Published: (2024)